BIOMAT Database Logo BIOMAT Database Logo

Correction to Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase. 2017

John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd

UI MeSH Term Description Entries

Related Publications

John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach.
March 2017, ACS medicinal chemistry letters,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Discovery of potent, selective chymase inhibitors via fragment linking strategies.
June 2013, Journal of medicinal chemistry,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Studies of metabolism and disposition of potent human immunodeficiency virus (HIV) integrase inhibitors using 19F-NMR spectroscopy.
September 2007, Xenobiotica; the fate of foreign compounds in biological systems,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
October 2014, Journal of medicinal chemistry,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Discovery of a series of selective and cell permeable beta-secretase (BACE1) inhibitors by fragment linking with the assistance of STD-NMR.
November 2019, Bioorganic chemistry,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Design of Potent and Highly Selective Inhibitors for Human β-Secretase 2 (Memapsin 1), a Target for Type 2 Diabetes.
May 2016, Chemical science,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Di-substituted pyridinyl aminohydantoins as potent and highly selective human beta-secretase (BACE1) inhibitors.
January 2010, Bioorganic & medicinal chemistry,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Development of potent inhibitors by fragment-linking strategies.
October 2022, Chemical biology & drug design,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors.
January 2012, Topics in current chemistry,
John B Jordan, and Douglas A Whittington, and Michael D Bartberger, and E Allen Sickmier, and Kui Chen, and Ryan D White, and Yuan Cheng, and Ted Judd
Using 19F NMR spectroscopy to determine trifluralin binding to soil.
December 2004, Environmental science & technology,
Copied contents to your clipboard!